{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:22:13Z","timestamp":1708993333545},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,26]]},"DOI":"10.7759\/cureus.54948","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T15:02:13Z","timestamp":1708959733000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Outcomes Between Milrinone and Dobutamine in Patients With Cardiogenic Shock: A Meta-Analysis of Randomized Control Trials and Observational Studies"],"prefix":"10.7759","author":[{"given":"Chenyue","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin R","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelum","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele H","year":"2019","unstructured":"Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019, 40:2671-83. 10.1093\/eurheartj\/ehz363","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen S","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, et al.. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017, 136:e232-68. 10.1161\/CIR.0000000000000525","journal-title":"Circulation"},{"key":"ref3","article-title":"Predictive value of extravascular pulmonary water index and cardiac index on the prognosis of patients with cardiogenic shock","volume":"37","author":"Chen C","year":"2014","unstructured":"Chen C, Zhao L, Li L, et al.. Predictive value of extravascular pulmonary water index and cardiac index on the prognosis of patients with cardiogenic shock. Chin J Circ. 2014, 37:895-8.","journal-title":"Chin J Circ"},{"key":"ref4","article-title":"Progress in diagnosis and treatment of cardiogenic shock and interpretation of guidelines","volume":"46","author":"Zhang S","year":"2017","unstructured":"Zhang S. Progress in diagnosis and treatment of cardiogenic shock and interpretation of guidelines. J Med Res. 2017, 46:9.","journal-title":"J Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Ouweneel DM","year":"2017","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, et al.. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017, 69:278-87. 10.1016\/j.jacc.2016.10.022","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.036614","article-title":"Impella support for acute myocardial infarction complicated by cardiogenic shock","volume":"139","author":"Schrage B","year":"2019","unstructured":"Schrage B, Ibrahim K, Loehn T, et al.. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019, 139:1249-58. 10.1161\/CIRCULATIONAHA.118.036614","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1488-x","article-title":"Decatecholaminisation during sepsis","volume":"20","author":"Rudiger A","year":"2016","unstructured":"Rudiger A, Singer M. Decatecholaminisation during sepsis. Crit Care. 2016, 20:309. 10.1186\/s13054-016-1488-x","journal-title":"Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy B","year":"2018","unstructured":"Levy B, Clere-Jehl R, Legras A, et al.. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018, 72:173-82. 10.1016\/j.jacc.2018.04.051","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13893","article-title":"Norepinephrine use in cardiogenic shock patients is associated with increased 30\u00a0day mortality","volume":"9","author":"Lu X","year":"2022","unstructured":"Lu X, Wang X, Gao Y, et al.. Norepinephrine use in cardiogenic shock patients is associated with increased 30\u00a0day mortality. ESC Heart Fail. 2022, 9:1875-83. 10.1002\/ehf2.13893","journal-title":"ESC Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071659","article-title":"The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis","volume":"8","author":"Pirracchio R","year":"2013","unstructured":"Pirracchio R, Parenica J, Resche Rigon M, et al.. The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One. 2013, 8:e71659. 10.1371\/journal.pone.0071659","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.01.016","article-title":"Inotropes","volume":"63","author":"Francis GS","year":"2014","unstructured":"Francis GS, Bartos JA, Adatya S. Inotropes. J Am Coll Cardiol. 2014, 63:2069-78. 10.1016\/j.jacc.2014.01.016","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000962","article-title":"Efficacy of milrinone and dobutamine in cardiogenic shock: an updated systematic review and meta-analysis","volume":"5","author":"Abdel-Razek O","year":"2023","unstructured":"Abdel-Razek O, Di Santo P, Jung RG, et al.. Efficacy of milrinone and dobutamine in cardiogenic shock: an updated systematic review and meta-analysis. Crit Care Explor. 2023, 5:e0962. 10.1097\/CCE.0000000000000962","journal-title":"Crit Care Explor"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.1599","article-title":"Dobutamine versus milrinone use in acute myocardial infarction related cardiogenic shock","volume":"44","author":"Ten Berg S","year":"2023","unstructured":"Ten Berg S, Peters EJ, Bogerd M, Timmermans MJ, Otterspoor LC, Vlaar AP, Henriques JP. Dobutamine versus milrinone use in acute myocardial infarction related cardiogenic shock. Eur Heart J. 2023, 44:655-1599. 10.1093\/eurheartj\/ehad655.1599","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.696138","article-title":"Inotrope use and intensive care unit mortality in patients with cardiogenic shock: an analysis of a large electronic intensive care unit database","volume":"8","author":"Gao F","year":"2021","unstructured":"Gao F, Zhang Y. Inotrope use and intensive care unit mortality in patients with cardiogenic shock: an analysis of a large electronic intensive care unit database. Front Cardiovasc Med. 2021, 8:10.3389\/fcvm.2021.696138","journal-title":"Front Cardiovasc Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1074248418797357","article-title":"Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock","volume":"24","author":"Lewis TC","year":"2019","unstructured":"Lewis TC, Aberle C, Altshuler D, Piper GL, Papadopoulos J. Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock. J Cardiovasc Pharmacol Ther. 2019, 24:130-8. 10.1177\/1074248418797357","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew R","year":"2021","unstructured":"Mathew R, Di Santo P, Jung RG, et al.. Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med. 2021, 385:516-25. 10.1056\/NEJMoa2026845","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/11795468211049449","article-title":"Predictors of in-hospital mortality in cardiogenic shock patients on vasoactive or inotropic support","volume":"15","author":"Nandkeolyar S","year":"2021","unstructured":"Nandkeolyar S, Doctorian T, Fraser G, et al.. Predictors of in-hospital mortality in cardiogenic shock patients on vasoactive or inotropic support. Clin Med Insights Cardiol. 2021, 15:10.1177\/11795468211049449","journal-title":"Clin Med Insights Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14379","article-title":"Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure","volume":"10","author":"Rodenas-Alesina E","year":"2023","unstructured":"Rodenas-Alesina E, Luis Scolari F, Wang VN, et al.. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure. ESC Heart Fail. 2023, 10:2577-87. 10.1002\/ehf2.14379","journal-title":"ESC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1300839","article-title":"Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database","volume":"10","author":"Sasmita BR","year":"2023","unstructured":"Sasmita BR, Wang C, Xie S. Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database. Front Cardiovasc Med. 2023, 10:10.3389\/fcvm.2023.1300839","journal-title":"Front Cardiovasc Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer D","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, et al.. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010, 362:779-89. 10.1056\/NEJMoa0907118","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.50","article-title":"Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial","volume":"145","author":"Aranda JM Jr","year":"2003","unstructured":"Aranda JM Jr, Schofield RS, Pauly DF, et al.. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Am Heart J. 2003, 145:324-9. 10.1067\/mhj.2003.50","journal-title":"Am Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.11.023","article-title":"Safety of outpatient milrinone infusion in end-stage heart failure: ICD-level data on atrial fibrillation and ventricular tachyarrhythmias","volume":"133","author":"Harhash AA","year":"2020","unstructured":"Harhash AA, Cassuto J, Hussein A, et al.. Safety of outpatient milrinone infusion in end-stage heart failure: ICD-level data on atrial fibrillation and ventricular tachyarrhythmias. Am J Med. 2020, 133:857-64. 10.1016\/j.amjmed.2019.11.023","journal-title":"Am J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/232282-comparison-of-outcomes-between-milrinone-and-dobutamine-in-patients-with-cardiogenic-shock-a-meta-analysis-of-randomized-control-trials-and-observational-studies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T15:02:19Z","timestamp":1708959739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/232282-comparison-of-outcomes-between-milrinone-and-dobutamine-in-patients-with-cardiogenic-shock-a-meta-analysis-of-randomized-control-trials-and-observational-studies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.54948","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,26]]}}}